64
Participants
Start Date
August 19, 2017
Primary Completion Date
December 30, 2026
Study Completion Date
December 30, 2026
Budesonide and Azithromycin
Participant with acute laryngeal injury will be randomized at discharge to either a non-drug placebo control group or a medical therapy group consisting of azithromycin 250 mg and budesonide 0.5 mg for 14 days.
Placebo control of budesonide and azithromycin
placebos of the medications will be given for 14 days in patients randomized to the control group
Vanderbilt University Medical Center, Nashville
Vanderbilt University Medical Center
OTHER